Evidence map›Paper›PMID 34378962›Full record

ArticleMicrobiology spectrum2021

Honeybee Exposure to Veterinary Drugs: How Is the Gut Microbiota Affected?

Loredana Baffoni, Daniele Alberoni, Francesca Gaggìa, Chiara Braglia, Catherine Stanton, Paul R Ross, Diana Di Gioia

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Hive-associated bacteria improve honeybee survival duringbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. EndophyticFrontiers in microbiology · 2025
    Article
  13. Frontiers in insect science · 2025
    Article
  14. Article
  15. Managing Microbiota Activity ofMicroorganisms · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Frontiers in cellular and infection microbiology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Loredana BaffoniDepartment of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.ORCID 0000-0001-5313-5871
Daniele AlberoniDepartment of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.ORCID 0000-0002-2394-2880
Francesca GaggìaDepartment of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.
Chiara BragliaDepartment of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.ORCID 0000-0002-1637-896X
Catherine StantonTeagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland.ORCID 0000-0002-6724-7011
Paul R RossTeagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland.
Diana Di GioiaDepartment of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.ORCID 0000-0002-0181-1572
University of Bologna · ITTeagasc - The Irish Agriculture and Food Development Authority · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have outlined that a balanced gut microbiota offers metabolic and protective functions supporting honeybee health and performance. The present work contributes to increasing knowledge on the impact on the honeybee gut microbiota of the three most common veterinary drugs (oxytetracycline, sulfonamides, and tylosin). The study was designed with a semi-field approach in micro-hives containing about 500 honeybees. Micro-hives were located in an incubator during the day and moved outdoors in the late afternoon, considering the restrictions on the use of antibiotics in the open field but allowing a certain freedom to honeybees; 6 replicates were considered for each treatment. The absolute abundance of the major gut microbial taxa in newly eclosed individuals was studied with qPCR and next-generation sequencing. Antimicrobial resistance genes for the target antibiotics were also monitored using a qPCR approach. The results showed that the total amount of gut bacteria was not altered by antibiotic treatment, but qualitative variations were observed. Tylosin treatment determined a significant decrease of α- and β-diversity indices and a strong depletion of the rectum population (lactobacilli and bifidobacteria) while favoring the ileum microorganisms (

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBeesBiodiversityGastrointestinal MicrobiomeOxytetracyclineSulfonamidesTylosinVeterinary DrugsAnti-Bacterial AgentsOxytetracyclineSulfonamidesTylosinVeterinary Drugsantibiotic resistancebifidobacteriaBombilactobacillushoneybeesLactobacillusmicrobiotanext-generation sequencingNGSsulphonamidestetracyclinestylosin

Identifiers

PMID34378962
PMCPMC8552759
OpenAlexW3187777277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.